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Abstract: The p38 MAPK signaling pathway has been suggested to play a significant role in the 18	
gastric mucosal inflammatory response to chronic Helicobacter pylori (H. pylori) infection. Nuclear 19	
translocation is thought to be important for p38 function, but no nuclear translocation signals have 20	
been found in the protein and no nuclear carrier proteins have been identified for p38. We have 21	
investigated the role of SUMO in the nuclear transfer of p38 in response to H. pylori infection. 22	
Exposure of human AGS cells to H. pylori induced the activation of p38 and the expression of 23	
SUMOs, especially SUMO-2. SUMO knockdown counteracted the effect of H. pylori infection by 24	
decreasing the resulting p38 mediated cellular apoptosis through a reduction in the nuclear 25	
fraction of phosphorylated p38. We identified a non-covalent interaction between SUMOs and p38 26	
via SUMO interaction motifs (SIMs), and showed that SUMO-dependent nuclear transfer of p38 27	
was decreased upon mutation of its SIMs. This study has identified a new pathway of p38 nuclear 28	
translocation, in response to H. pylori infection. We conclude that in the presence of H. pylori 29	
SUMO-2 has a major role in regulating nuclear levels of p38, through non-covalent SUMO-p38 30	
interactions, independent of the p38 phosphorylation state. 31	
Keywords: Helicobacter pylori; nuclear transfer; p38; signal pathway; SIM; SUMO-2 32	
 33	
1. Introduction 34	
Environmental insults such as oxidative stress and hypoxia can induce the activation of the p38 35	
mitogen activated protein kinase (MAPK) signaling pathway causing a variety of cellular responses 36	
such as apoptosis1, 2. p38 MAPK is activated following phosphorylation at Thr180/Tyr182 within the 37	
activation loop (p-p38), primarily by upstream MKK3 and MKK63. p38 MAPK has been shown to 38	
be distributed throughout the cytosol and nucleus4. Phosphorylation-dependent nuclear 39	
translocation of p38 has been reported to be a common phenomenon when cells are stimulated by 40	
various stresses5. However, no nuclear translocation signals (NTSs) have been found in p38 and no 41	
nuclear carrier proteins have been identified for it. It is therefore unclear how nuclear translocation 42	
of p38 is achieved6-9.  43	
Helicobacter pylori (H. pylori or Hp) is thought to induce gastric epithelial inflammation and 44	
apoptosis, and can interfere with the ulcer healing process within the stomach. Oxidative stress and 45	
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cellular apoptosis have been observed in H. pylori infected gastric tissue, which may be due to 46	
inflammation caused by overproduction of cytokines stimulated by the infection10, 11. The p38 47	
MAPK signaling pathway has been suggested to play a significant role in the gastric mucosal 48	
inflammatory response to chronic H. pylori infection via prostaglandin E212. MAPK activation, 49	
particularly via JNK and p38, is more potently induced by Cag+ compared with Cag--strains of 50	
clinical H. pylori13. The toxin Vac-A of Vac+ H. pylori strains may induce apoptosis through 51	
differential regulation of ERK1/2 and p38 MAPK14.  52	
The small ubiquitin-related modifier (SUMO), an important post-translational modifier, has 53	
been implicated in a wide range of cellular processes including intracellular targeting, response to 54	
extracellular stimuli, transcriptional regulation, differentiation, cytoplasmic to nuclear translocation 55	
and apoptosis15-19. SUMO-1 has a major role in the formation of promyelocytic leukemia nuclear 56	
bodies (PML-NBs), which appear in response to viral infections20 and environmental stresses, 57	
including oxidative stress21. When cells were subjected to protein-damaging stimuli via heat shock 58	
and ethanol addition, resulting in oxidative stress, large quantities of free, non-conjugated SUMO-2 59	
were produced and high levels of SUMO-2 conjugates were detected. Under such stresses SUMO-2 60	
was found to be more abundant than SUMO-116. SUMO has previously been shown to be important 61	
for nuclear transport of certain proteins not only by covalent modification but also by non-covalent 62	
interaction. For example, the SAE2 subunit of human SUMO activation enzyme has been shown to 63	
be dependent on SUMOylation at its C terminus for nuclear localization22. In contrast non-covalent 64	
association of parkin with SUMO-1 results in an increase in the nuclear transport of parkin15. In 65	
addition, our previous study showed that although Daxx protein usually depends on a nuclear 66	
localization signal (NLS) for transport from the cytoplasm to the nucleus, NLS mutated Daxx can be 67	
transferred from the cytoplasm to the nucleus by utilizing SUMOs as carrier proteins in co-68	
expressing cells18. It has previously been shown that SUMOs may have differing binding affinities 69	
for various substrates, e.g., TNF receptor-associated protein (TRAF) preferentially binds to SUMO-2 70	
whilst Ran binding-protein 2 (RanBP2) preferentially binds to SUMO-123, and Bloom syndrome 71	
protein binds SUMO-2 in preference to SUMO-124. GST-Daxx has previously been observed to be 72	
strongly modified by SUMO-1 and weakly modified by SUMO-2 25. In this study we have found 73	
that SUMOs (in particular SUMO-2) were upregulated in AGS cells in response to H. pylori 74	
infection, in parallel with p38 activation. Therefore, SUMO-1 and SUMO-2 were examined for their 75	
roles in nuclear translocation of p38. Here we show that SUMO-2 mediates H. pylori induced p38-76	
dependent apoptosis via the translocation of p38 to the nucleus in response to H. pylori infection.  77	
2. Results 78	
2.1. The association between up-regulation of SUMOs and activation of the p38 pathway, in response to H. 79	
pylori infection 80	
Previous studies have shown that SUMOs are increased in response to various stresses16, 26, 27  81	
and that p38 mRNA and protein are increased in response to H. pylori infection or in response to the 82	
H.pylori cytotoxins VacA and CagA13, 14, 28, hence our first steps were to measure SUMOs and p38 83	
mRNAs and proteins in response to H. pylori infection. We chose the strongly virulent H. pylori 84	
strain ATCC 43504 (CagA+, VacA+) for our studies, as less virulent strains (e.g., CagA negative 85	
strains) would be expected to produce a weaker p38 response. The mRNA levels of SUMO-1 and 86	
SUMO-2 (Figure 1A), and p38 (Figure 1B) were up-regulated at increasing periods of time during 87	
H. pylori infection. Similarly, increased protein expression levels for SUMO-1 and SUMO-2 (Figure 88	
1C), as well as p38 and p-p38 (Figure 1D) were seen in response to chronic H. pylori infection over a 89	
period of 24 hours. An increase in the activated form of p38 (p-p38) was also seen after shorter 90	
periods of H. pylori infection (Supplementary Figure 1B) although total p38 did not increase under 91	
these conditions. Similar early induction of p-p38 one hour after H. pylori infection has been shown 92	
previously13. It has also previously been shown that a large pool of free, non-conjugated SUMO-2 93	
was induced in response to various stresses and that SUMO-2 was more abundant than SUMO-1. In 94	
this study, induction of high levels of SUMOs under the infective stress of H. pylori infections was 95	
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reflected in the increase in the total conjugated forms of SUMOs, and in agreement with previous 96	
studies SUMO-2 was more abundant than SUMO-1 (Figure 1C). 97	
 98	
Figure 1. H. pylori infection induces the expression of SUMO-1, SUMO-2, p38 and p-p38 in AGS 99	
cells. Total RNA was isolated from AGS cells infected with H. pylori for 15, 30, 45 and 60 minutes 100	
(black bars). The mRNA expression levels of SUMO-1, SUMO-2, p38 and GAPDH were obtained by 101	
RT-PCR. The mRNA expression levels of (A) SUMO-1 and SUMO-2 and (B) p38, were up-regulated 102	
with increasing periods of time during H. pylori infection, as indicated, normalized to the mRNA 103	
levels observed in uninfected cells (white bar). Each experiment in (A) and (B) was repeated at least 104	
three times and all data are represented in the plots as the mean +/- the standard deviation. 105	
Differences between each group and the Hp (-) condition were evaluated by an independent 106	
Student’s t-test using SPSS version 16.0 (SPSS Inc., USA). p<0.05 (*) was considered significant. 107	
Representative gels are shown in each case. Western blot analysis showed that the protein 108	
expression levels of SUMO-1 and SUMO-2 (C; lanes 2-6 and lanes 8-12), and p-p38 and p38 (D; lanes 109	
2-6), were up-regulated with increasing periods of time following H. pylori infection for 1, 3, 6, 12 110	
and 24 hours. In a separate experiment (Supplementary Figure 1B) early upregulation of p-p38 was 111	
seen after only 45 minutes. The early upregulation is not apparent here (D; 1 hour) as the exposure 112	
time was limited to avoid saturation at later time points. In the case of SUMOs the increase is 113	
apparent in the conjugated forms of the proteins, and SUMO-2 up-regulation was greater than that 114	
of SUMO-1 in response to H. pylori infection (C). The experiments in (C) and (D) were repeated 115	
three times and representative images are shown. 116	
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Supplementary Figure 1. The effects of Hp infection on cell survival and on the levels of p-p38 118	
expression. (A) H. pylori induced apoptosis is associated with SUMOs. The levels of cell survival for 119	
various transfectants (siControl, siSUMO-1 and siSUMO-2) without H. pylori infection (white bars) 120	
or with H. pylori infection (black bars) were examined in AGS cells using MTT assays. In the absence 121	
of H.pylori infection a reduction in cell survival was observed in siSUMO-1 and siSUMO-2 122	
transfectants compared with siControl (white bars in groups 3 and 4 compared with that in group 123	
2). However, H. pylori infection induced a reduction in cell survival in untransfected and siControl 124	
transfected AGS cells (white bars compared with black bars in groups 1 and 2).  The knock down of 125	
SUMO-1 (group 3 siSUMO-1) and SUMO-2 (group 4 siSUMO-2) up-regulated cell survival in H. 126	
pylori infected cells compared with siControl transfectants (black bars in groups 3 and 4 compared 127	
with black bar in group 2). These results show that endogenous SUMOs mediate the H. pylori 128	
induced apoptosis. The MTT assays were repeated four times and the results shown are the mean 129	
+/- standard deviation. Statistical analyses were performed using Student's T test. p<0.05 was 130	
considered significant; *= p<0.05; **= p<0.01; ***= p<0.001*= p<0.05; **= p<0.01; ***= p<0.001.  131	
(B) Overexpression of SUMOs enhance endogenous p38 phosphorylation.  RFP-SUMO-1 and RFP-132	
SUMO-2 transfectants were incubated for 12 hours before being infected with H. pylori (300 MOI, 45 133	
min) and the levels of phosphorylated p38 were analyzed by Western blot (top panel). 134	
Quantification of the bands in the Western blot (B; lower panel) showed that H. pylori infection 135	
resulted in increased p-p38 compared with uninfected cells. Significant increases in phosphorylated 136	
p38 (p-p38) were observed both in RFP-SUMO-1 and RFP-SUMO-2 overexpression cells (groups 3 137	
and 4 respectively) versus RFP (group 2) with or without H. pylori infection. The p values obtained 138	
for the data in Supplementary Figure 1A and 1B are summarized in Supplementary Table 1. The 139	
Western blots were repeated three times and representative images are shown (top panel of (B)) 140	
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Supplementary Table 1: Summary of the p values for statistical analyses for comparison of the data 142	
from Supplementary Figure 1 with (+) and without (-) H. pylori infection A) p values from the MTT 143	
assays (Supplementary Figure 1A) used to assess the effects on cell survival of knock down of 144	
SUMOs using siSUMO-1 and si-SUMO-2; and B) p values from quantification of Western blots 145	
(Supplementary Figure 1B) used to assess the changes in phosphorylated p38 resulting from 146	
overexpression of SUMOs, using RFP-SUMO-1 and RFP-SUMO-2. Statistical analyses were 147	
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performed using Student's T test. p<0.05 was considered significant; *= p<0.05; **= p<0.01; ***= 148	
p<0.001. 149	
Hence, our results and those documented previously showed that p38-MAPK signaling 150	
increased in the presence of H. pylori infection. Previous papers showed that SUMOs increased in 151	
response to various stressors, and we have demonstrated that SUMOs, and in particular SUMO-2 152	
increased in response to H. pylori infection (Figure 1C). p-p38 must be transported to the nucleus to 153	
exert its effects, and a well-known role of SUMOs is to alter sub-cellular localization. Therefore, we 154	
decided to see whether there was a link between SUMOs and p38 activity (namely p38-mediated 155	
apoptosis), and also between SUMOs and p38 localization within the cell. 156	
In order to examine the influence of SUMO on the p38-mediated apoptotic pathway in 157	
response to H. pylori infection, the MTT assay for cell survival was performed in siSUMO and RFP-158	
SUMO transfectants with or without p38-MAPK inhibitor SB203580 (Figure 2). Cell survival levels 159	
were significantly higher upon inhibition of the p38-MAPK pathway in SB203580 pretreated cells in 160	
each case (Figure 2, black bar vs. white bar; see also the summary of statistical analyses in 161	
Supplementary Table 2).  162	
Quantification of Western blot data showed the decrease in the levels of endogenous SUMO-1 163	
and SUMO-2 in siSUMO-1 and siSUMO-2 transfectants respectively (Figure 2A, top panel), while 164	
RFP-SUMO-1 and RFP-SUMO-2 fusion proteins were used to increase levels of SUMO-1 and 165	
SUMO-2 (Western blot in Figure 2B, top panel).  We also observed that siSUMO-1 produced a small 166	
but significant decrease in SUMO-2 levels. This is consistent with a non-specific effect of siSUMO-1 167	
on SUMO-2. The knockdown of SUMO-1 and SUMO-2 increased cell survival in H. pylori infected 168	
AGS cells (Supplementary Figure 1A, groups 3 and 4 vs. group 2; Supplementary Table 1; and 169	
Figure 2A, Lower panel, groups 3 and 4 vs. group 2). In contrast comparisons between RFP-SUMO-170	
1 or RFP-SUMO-2 transfectants with the RFP control transfectants (Figure 2B, lane 3 and lane 4 vs. 171	
lane 2 respectively) showed that overexpression of SUMOs lead to a significant decrease in cell 172	
survival in RFP-SUMOs expressing cells. This effect was partially rescued when SUMOs 173	
overexpression was accompanied by treatment with the p38 pathway inhibitor SB203580, consistent 174	
with at least part of the SUMOs effect being via p38-mediated apoptosis. This incomplete rescue can 175	
be explained firstly, because p38-mediated apoptosis is not the only apoptotic pathway to be 176	
induced during H. pylori infection13 we cannot rule out an effect of SUMOs on such alternative 177	
pathways too. Secondly, although SB203580 is the most effective inhibitor for the p38 pathway it 178	
would not be expected to completely block it. We note that in addition to the large knockdown of 179	
SUMO-1 by si-SUMO-1, the small but significant knockdown of SUMO-2 by si-SUMO-1 may 180	
contribute to the increased cell survival in this case. However, the misexpression of SUMO-1 and 181	
SUMO-2 both resulted in decreased cell survival confirming that SUMO-1, like SUMO-2 is capable 182	
of affecting cell survival via p38-mediated apoptosis. 183	
With respect to the p38 pathway we found that overexpression of SUMOs enhanced 184	
endogenous p38 phosphorylation as shown in Supplementary Figure 1B (see also Supplementary 185	
Table 1 for statistical analyses), and SUMOs were found to colocalize with p-p38 in nuclear dots in 186	
cells overexpressing SUMOs as shown in Supplementary Figure 2. Taken together these results 187	
demonstrate that the levels of SUMOs in cells have an impact on p38 mediated apoptosis possibly 188	
via direct interaction between SUMOs and p38.  189	
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Figure 2.SUMOs-dependent reductions in cell survival during H. pylori infection arise due to p38-191	
mediated apoptosis. The levels of H. pylori induced apoptosis for various transfectants (A) siSUMO-192	
1, siSUMO-2, siControl, and (B) RFP-vector, RFP-SUMO-1 and RFP-SUMO-2 were examined in AGS 193	
cells by MTT assays, in which SB203580 (p38 MAPK inhibitor) was used to assess the role of the 194	
p38-mediated apoptotic pathway. A) Upper panel: The knockdown of SUMO-1 and SUMO-2 by 195	
siSUMO-1 and siSUMO-2 respectively was confirmed by quantification of Western blot data. We 196	
also noticed a small but significant non-specific reduction of SUMO-2 by si-SUMO-1. Lower panel: 197	
The increased cell survival in each group of SB 203580 pretreated cells (black bars vs. white bars; see 198	
Supplementary Table 2 for summary of statistical analyses) during H. pylori infection showed that 199	
p38 was involved in H. pylori induced apoptosis. Cell survival was significantly increased in 200	
siSUMO-1 and siSUMO-2 transfectants (siSUMO-1 or siSUMO-2 vs. siControl) with or without 201	
SB203580. B) Upper panel: The expression of RFP, RFP-SUMO-1 and RFP-SUMO-2 respectively was 202	
confirmed by Western blotting. Lower panel: In contrast to the si-SUMOs data, cell survival 203	
decreased in RFP-SUMO-1 and RFP-SUMO-2 expressing cells (RFP-SUMO-1 or RFP-SUMO-2 vs. 204	
RFP). This effect was reversed by the use of the p38 MAPK inhibitor SB203580 (compare black bars 205	
to white bars in groups 3 and 4), showing that the effect of SUMOs depends on activated p38. This is 206	
consistent with SUMOs reducing cell viability via the p38-mediated apoptotic pathway.. *= p<0.05; 207	
**= p<0.01; ***= p<0.001. The Western blots shown in the upper panels were repeated three times and 208	
the results shown in A) are the mean +/- standard deviation of these three repeats. In B) a 209	
representative image of the three repeats is shown. The MTT assays in the lower panel were repeated 4 210	
times for each condition and the results shown are the mean +/- standard deviation. All data were 211	
evaluated by independent Student’s t-test using SPSS version 16.0 (SPSS Inc USA). p<0.05 was 212	
considered significant. The p values obtained for the data shown in Figure 2A and Figure 2B have 213	
been summarized in Supplementary Table 2 214	
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Supplementary Table 2: Summary of the p values for statistical analyses for comparison of the data 216	
with and without the p38 MAPK inhibitor SB203580 from Figure 2. The data are shown for 217	
SB203580 (+) vs. SB203580 (-) conditions for A) experiments to knock down SUMOs using siSUMO-1 218	
and si-SUMO-2 and B) experiments where SUMOs were overexpressed, using RFP-SUMO-1 and 219	
RFP-SUMO-2, as shown in the lower panels of Figure 2A and B. Statistical analyses were performed 220	
using Student's T test. These results show that the increase in cell survival in the presence of the 221	
inhibitor compared with its absence is significant for all pairwise comparisons. p<0.05 was 222	
considered significant; *= p<0.05; **= p<0.01; ***= p<0.001 223	
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Supplementary Figure 2. Endogenous p-p38 co-localized with RFP-SUMOs in the nucleus and its 225	
levels were increased during Hp infection. The cellular localization of phosphorylated p38 was 226	
analyzed using p-p38/FITC antibodies in AGS cells and RFP-SUMO-1 and RFP-SUMO-2 transfected 227	
cells that were incubated for 12 hours before being infected with H. pylori (300 MOI, 12 hours). In 228	
untransfected AGS cells dispersed endogenous nuclear p-p38 was observed in both non-infected 229	
cells (Panel A) and Hp infected cells (Panel D). Comparison of panel A and D showed that nuclear 230	
p-p38 was higher in the Hp infected cells. In RFP-SUMOs overexpressing cells p-p38 co-localized 231	
with RFP-SUMOs in nuclear dots both in non-Hp infected cells (group B and group C) and in 232	
infected cells (group E and group F). p-p38 was increased during Hp infection (group E vs. group B, 233	
and group F vs. group C). All experiments were repeated three times and representative images are 234	
shown. 235	
2.2. The nuclear localization of p38 and p-p38 is dependent on the levels of SUMOs 236	
To further investigate the function of SUMOs in relation to p38 proteins during H. pylori 237	
infection, p38 and p-p38 in nuclear or cytoplasmic subcellular fractions of siSUMO (Figure 3A) and 238	
RFP-SUMO (Figure 3B) transfectants were analyzed with or without H. pylori infection. In whole 239	
cell lysate (WCL) endogenous p-p38 was up-regulated (Figure 3A, right panel, groups 1-4 240	
compared with left panel, groups 1-4) in response to Hp infection. Endogenous SUMO-1 (Figure 3A, 241	
group 3) and SUMO-2 (Figure 3A, group 4) were down-regulated after transfection of siSUMO-1 242	
and siSUMO-2 with or without Hp infection. Without Hp infection p38 and p-p38 in the nuclear 243	
fraction (N-fraction) were decreased in siSUMO-1 (Figure 3A, left panel, group 3) and siSUMO-2 244	
(Figure 3A, left panel, lane 4) transfectants. This suggests that SUMO-1 and SUMO-2 share the same 245	
role in regulation of nuclear levels of p38 and p-p38 when cells are in their resting state (without H. 246	
pylori infection). However, during Hp infection a decrease in levels of p38 and p-p38 in the N-247	
fraction occurred only in siSUMO-2 transfectants (Figure 3A, right panel, group 4), but not in 248	
siSUMO-1 transfectants (Figure 3A, right panel, group 3). This result suggests that there may be 249	
different mechanisms by which SUMOs regulate nuclear levels of p38 and p-p38 with or without 250	
stimulation i.e., both SUMOs have a role in the absence of stimuli, whereas after stimulation it is 251	
SUMO-2 that has the major role in transporting p38 to the nucleus. The same nuclear fractionation 252	
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assay was performed in RFP-SUMO expressing cells (Figure 3B). RFP-vector (RFP) was used as a 253	
control for the RFP-fusion fragment without SUMO. In response to Hp infection, both p38 and p-254	
p38 proteins were significantly up-regulated in the N-fraction but decreased in the cytoplasmic 255	
fraction (C-fraction) in the RFP-SUMO-2 expressing cells (Figure 3B, right panel, group 4) compared 256	
to RFP-vector (Figure 3B, right panel, group 2) and RFP-SUMO-1 (Figure 3B, right panel, group 3) 257	
transfectants. These results suggest that SUMO-2 has a major role in regulating the nuclear levels of 258	
p38 and p-p38 in response to H. pylori infection. 259	
 260	
Figure 3. SUMO-2 is more efficient than SUMO-1 in regulating nuclear p38 and p-p38 during H. 261	
pylori infection. The cytoplasmic and nuclear fractions of p38 and p-p38 were analyzed from 262	
siSUMO transfectants (A) and RFP-SUMO transfectants (B). p38 and p-p38 were blotted with anti-263	
p38 and anti-p-p38 antibodies. SUMO-1 and SUMO-2 were detected using anti-SUMO-1 and anti-264	
SUMO-2 antibodies. RFP alone or fusion proteins of RFP-SUMO-1 or RFP-SUMO-2, were detected 265	
using anti-RFP. GAPDH and Lamin A/C were used as cytosolic and nuclear markers respectively. 266	
For α-SUMO-1 and α-SUMO-2 the upper panels show conjugated SUMOs while the lower panels 267	
show free-form SUMOs. (A), Western Blots showed that the endogenous SUMO-1 and SUMO-2 268	
were down-regulated after transfectional incubation of siSUMO-1 and siSUMO-2. p38 and p-p38 in 269	
the N-fraction were decreased in siSUMO-1 and siSUMO-2 transfectants without H. pylori infection; 270	
however, their nuclear levels decreased only for siSUMO-2 and not for siSUMO-1 transfectants 271	
during H. pylori infection. (B), Western Blots showed that RFP-SUMO-1 and RFP-SUMO-2 fusion 272	
proteins were up-regulated after transfectional incubation. p38 and p-p38 levels were up-regulated 273	
in the N-fraction and clearly down-regulated in the C-fraction in RFP-SUMO-2 transfectants during 274	
H. pylori infection. Quantification of the blots shown in (A) and (B) is summarized in Supplementary 275	
Table 3 below. All experiments were repeated three times and representative images are shown. 276	
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Supplementary Table 3: Quantification of the Western blot data shown in Figure 3A. The upper 278	
panel shows the values for the quantification of the bands for Hp- and Hp+ conditions. The values 279	
highlighted in green show the increase in nuclear p38 and p-p38 for Hp+ compared with Hp- 280	
conditions. The lower panel shows the values after normalization of the results to those for the 281	
untransfected AGS cells in each fraction. These values show the down-regulation of the SUMO-1 282	
and SUMO-2 after transfection of siSUMO-1 and siSUMO-2 (yellow and pink blocks), and the effect 283	
on p38 levels (brown and blue blocks). The brown blocks highlight conditions with little or no effect 284	
on p38 while blue blocks show conditions giving major reductions in p38 or p-p38 levels. In the 285	
absence of H.pylori infection p38 and p-p38 were decreased in both siSUMO-1 and siSUMO-2 286	
transfectants. However, during H. pylori infection the nuclear levels of p38 and p-p38 only 287	
decreased in siSUMO-2 transfectants. 288	
2.3. SUMO mediated nuclear transfer of p38 and p-p38 is SIM dependent 289	
Our results (Figure 3) showed that SUMO-2 has a major role in regulating the nuclear levels of 290	
p38 and p-p38 in response to H. pylori infection. In order to explain the association between levels of 291	
SUMOs and p38, and the connections between SUMOs and p38-mediated apoptosis in response to 292	
H. pylori infection, we hypothesized that SUMO may be involved in the nuclear transfer of p38. To 293	
investigate this hypothesis, we tested the possibility that a SUMO interacting motif (SIM) on p38 294	
could be the interaction site. SIMs have been identified in many SUMOylation substrates, such as 295	
RanBP2/Nup358 and SUMO ligases PIASX23, 29. SIMs are characterized by a loose consensus 296	
sequence and variants are plentiful. It has become evident that hydrophobic residues are  297	
quintessential components of SIMs30; hence we mutated hydrophobic residues in three predicted 298	
SIMs in p38 and tested the effect on binding to SUMOs.  299	
The GST fusion proteins of p38-WT (p38-WT, a full length p38 containing 360 amino acid 300	
residues) and the SIM mutants p38-SIM1*, p38-SIM2* and p38-SIM3* (full length p38 with 301	
mutations in SIMs1, 2 and 3 respectively) were constructed as shown in Figure 4A and the binding 302	
ability to His-SUMO-1 and His-SUMO-2 were analyzed using a pull-down assay. The binding of 303	
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SUMO-2 to p38-SIM3* was clearly abolished (Figure 4B group 8; Pull-down) and that to GST-p38-304	
SIM1* and GST-p38-SIM2* were significantly decreased (Figure 4B, groups 6-7; Pull-down) 305	
compared to that of wild type p38, GST-p38-WT (Figure 4B, group 5; Pull-down). The binding of 306	
SUMO-1 to p38 was too weak to detect, unless a longer exposure time was used (Figure 4B groups 307	
1-4; Pull-down; compare the long and short exposures).  308	
 309	
Figure 4. The SUMO binding abilities of p38 were decreased in SIM mutants. (A), Predicted SIMs 310	
from three SUMO-p38 interacting fragments (see Materials and Methods) were individually 311	
mutated in the context of full-length p38 to give three full length p38-SIM mutants with two amino 312	
acid residues mutated in each. (B), GST-p38-WT and GST-p38-SIM1*, GST-p38-SIM2* and GST-p38-313	
SIM3* expression constructs were used for in vitro SUMOs pull-down assays. Purified His-SUMOs 314	
and Ni-NTA-beads were mixed before addition of the target GST-p38-WT and GST-p38-SIM1*, 315	
GST-p38-SIM2* and GST-p38-SIM3* fusion proteins followed by incubation to form complexes of 316	
bead-conjugated-His-SUMOs and GST-p38. SUMO to p38 ratios of 1:1 were used. The binding 317	
affinities of SUMO-2 for all three p38-SIM mutants were decreased compared to wild type, 318	
especially for p38-SIM3*. Binding of p38 by SUMO-1 is much weaker than by SUMO-2, and could 319	
only be seen for p38-WT after long exposure of the Western blot. All experiments were repeated 320	
three times and representative images are shown. 321	
Next we analysed these interactions in AGS cells (Figure 5). The cytosolic-fractions (C-322	
fractions) and the nuclear-fractions (N-fractions) of the RFP-vector (negative control for SUMO 323	
proteins), RFP-SUMO-1, RFP-SUMO-2, and pCMV5-p38-WT and mutants (pCMV5-p38-SIM1*, 324	
pCMV5-p38-SIM2*, pCMV5-p38-SIM3*) co-expressing cells in response to H. pylori infection were 325	
analyzed as shown in Figure 5. The results demonstrate that, in comparison to p38-WT, increased 326	
nuclear transfer of p38 and p-p38 were slightly decreased in RFP-SUMO-2/p38-SIM1* or RFP-327	
SUMO-2/p38-SIM2* co-expression cells (Figure 5: lane 6 or 9 cf lane 3 in N-fraction panel) and 328	
abolished in the RFP-SUMO-2/p38-SIM3* co-expressing cells (Figure 5: lane 12 vs. lane 3 in N-329	
fraction panel). Similar effects were observed in RFP-SUMO-1/p38-SIM mutants co-expressing cells, 330	
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but not as clearly as for SUMO-2. We therefore concluded that SUMOs are involved in mediating 331	
the nuclear transfer of both p38 and p-p38 through interactions between SUMOs and the p38 SIMs, 332	
and that p38-SIM3 at amino acid residues 289-292 (LVLD) is the major interacting site. 333	
 334	
Figure 5. The nuclear transfer of p-p-38 and p38 by SUMOs was decreased for p38 SIM mutants. 335	
Cellular fractionation assays during H. pylori infection were used to evaluate the nuclear transfer 336	
abilities of SUMOs for p38-SIM mutants in AGS cells cotransfected with constructs expressing p38 337	
variants as indicated together with expression constructs for RFP, RFP-SUMO-1 or RFP-SUMO-2. A 338	
significant decrease in the nuclear levels of p38-SIM3* and a mild decrease in the nuclear levels of 339	
p38-SIM1* and p38-SIM2* were observed compared with p38-WT, in particular in the presence of 340	
RFP-SUMO-2, for both p38 and p-p38. All experiments were repeated three times and 341	
representative images are shown. 342	
2.4. SUMO interacts with p38 non-covalently  343	
Our results (Figure 5) showed that SUMO-2 has a major role in regulating the nuclear levels of 344	
both p38 and p-p38 through their SIMs in response to H. pylori infection. It has previously been 345	
shown that SUMOs may have differing binding affinities for various substrates, and our pull-down 346	
results in Figure 4 suggested that the SUMO-2-p38 interaction was stronger than the SUMO-1-p38 347	
interaction, therefore, we next sought to investigate the effect of the p38 phosphorylation state on 348	
the binding affinities of SUMO-1 and SUMO-2 to p38 and p-p38. In order to investigate a non-349	
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phosphorylatable form of p38 the GST-p38-DN protein expression construct was made, containing 350	
full length p38 with the two phosphorylation sites at amino acid residues 180 and 182 mutated. The 351	
resulting protein p38-DN functions as a dominant negative protein. Phosphorylated GST-p38-WT 352	
(GST-p-p38-WT) was produced by using the ATP regeneration system in the in vitro SUMOylation 353	
reactions. His-fused SUMO-1 and SUMO-2 proteins were used to pull-down GST-p38-DN, GST-354	
p38-WT and GST-p-p38-WT proteins to compare the binding affinity to p38 for SUMO-1 versus 355	
SUMO-2 (SUMOs to p38 ratio of 1:1) (Figure 6A). Figure 6A shows the input for reactions blotted 356	
with anti-p-p38 antibody, anti-p38 antibody, anti-GST antibody and anti-His antibody in the left 357	
panel, and the corresponding pull-downs in the right panel. The pull-down results (Figure 6A, right 358	
panel, groups 4-6) demonstrate that SUMO-2 pull-down products for GST-p38-DN, GST-p38-WT 359	
and GST-p-p38-WT were clearly observed; however, no SUMO-1 pull-down products were 360	
observed (Figure 6A, right panel, groups 1-3).  361	
 362	
Figure 6. SUMO-2 binds to p38-DN, p38-WT and p-p38 non-covalently. GST-p38-WT and GST-p38-363	
DN expression constructs were used for in vitro SUMOs pull-down assay and SUMOylation assay. 364	
GST-p-p38, for the in vitro SUMOs pull-down assay, was obtained by incubating GST-p38-WT with 365	
an ATP regeneration system. Purified His-SUMOs and Ni-NTA-beads were mixed before the target 366	
GST-p38-WT, GST-p38-DN and GST-p-p38 fusion proteins were added and incubated in order to 367	
form complexes of bead-conjugated-His-SUMOs and GST-p38. A SUMO to p38 ratio of 1:1 was 368	
used. (A), The blots for input proteins and the pull down proteins were probed with antibodies. 369	
SUMO-2 can pull-down GST-p38-DN, GST-p38-WT and GST-p-p38, but SUMO-1 is unable to do so 370	
at the SUMO to p38 ratio of 1:1. (B), In vitro SUMOylation assays were done as previously 371	
described24 and SUMOylation products were discerned by immunoblot analysis. No newly formed 372	
SUMOylation products were observed in the reactions for GST-p38-WT or GST-p38-DN, although 373	
SUMOylation products (marked with asterisks) were observed for the positive control GST-Daxx4 374	
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(a GST fusion of a tail fragment of Daxx, 607 -740aa, with a total molecular mass of 50kDa). All 375	
experiments were repeated three times and representative images are shown. 376	
These results confirm that SUMO-2 has a better binding affinity for p38 (regardless of 377	
phosphorylation state) compared to SUMO-1. However, when the levels of SUMO to p38 were 378	
increased to a ratio of 5:1, both SUMO-2 and SUMO-1 clearly interact with p-p38-WT and with p38-379	
DN (Supplementary Figure 3). This confirms that in vitro SUMOs interact with both non-380	
phosphorylated and phosphorylated p38 (p38 and p-p38 respectively). 381	
 382	
Supplementary Figure 3. Both SUMO-1 and SUMO-2 bind to p38-DN, p38-WT and p-p38 at a high 383	
SUMO to p38 ratio. The pull down assay conditions were the same as for Figure 6 except a SUMO to 384	
p38 ratio of 5:1 (rather than 1:1) was used. The blots for input proteins and the pull down proteins 385	
were probed with antibodies as indicated. These results show that at the higher SUMO to p38 ratios 386	
SUMO-1 can pull-down GST-p38-DN, GST-p38-WT and GST-p-p38 in a similar manner to SUMO-2. 387	
This is in contrast with the results at the lower SUMO to p38 ratio (1:1 in Figure 6) where only 388	
SUMO-2 gave efficient pulldowns. All experiments were repeated three times and representative 389	
images are shown. 390	
Since interactions between SUMOs and p38 were observed in direct pull-down of p38 and p-391	
p38 by SUMOs, in vitro SUMO modification assays (Figure 6B) were performed to determine 392	
whether p38 is a substrate for SUMOylation. GST-p38-WT (group 1) and GST-p38-DN (group 2) 393	
were used as SUMOylation substrates, GST-Daxx4 (a Daxx tail fragment fused to GST) functioned 394	
as a SUMOylation positive control (group 3); GST only protein (group 4) and SUMOylation 395	
enzymes (GST-SAE1/SAE2 and GST-Ubc9) (group 5) were two negative controls as GST-Ubc9 396	
(group 5), although itself a substrate for SUMOylation was at too low a level for us to detect 397	
SUMOylation under these assay conditions. Reactions were either in the presence or absence of 398	
SUMOs as indicated in Figure 6B. Anti-GST antibody was used to identify the following proteins: 399	
GST-p38-WT, GST-p38-DN, GST-Daxx4, GST, GST-Ubc9 and newly formed SUMOylation GST-400	
fusion protein conjugates. p38 variants were detected using anti-p38 and anti-p-p38. Figure 6B 401	
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shows that except for the positive control GST-Daxx4 (Figure 6B, group 3), no newly formed 402	
SUMOylation products were observed in the reactions (comparing His-SUMOs (+) with His-403	
SUMOs (-) lanes). The assay was repeated several times and the blots overexposed (results not 404	
shown) in order to check for any indication of SUMOylated p38 species, but none were found. 405	
These results suggest that GST-p38-WT and GST-p38-DN are not SUMOylation substrates for 406	
SUMO-1 or SUMO-2, consistent with interactions between SUMOs and p38 being predominantly 407	
non-covalent in nature.  408	
2.5. SUMO-mediated nuclear localization of p38 is independent of p38 phosphorylation 409	
The MAPK protein, p38, has previously been observed in both the cytoplasm and nucleus, but 410	
the transport mechanism into the nucleus was unclear. Previously, phosphorylation-dependent 411	
nuclear transfer of p38 has been suggested as the transport mechanism. However, our nuclear 412	
fractionation studies (Figure 3) showed that the nuclear localization of endogenous p38, similar to 413	
that of p-p38, is linked to the cellular levels of SUMOs. To examine the association between non-414	
phosphorylated p38 and SUMOs, the pCMV5-p38-WT and pCMV5-p38-DN mammalian expression 415	
constructs were used. The roles of SUMOs in mediating nuclear location of p38-DN were further 416	
demonstrated using cellular fractionation assays (Figure 7A). The levels of p38-WT, p-p38-WT and 417	
p38-DN in C- and N-fractions were analyzed for RFP-vector, RFP-SUMO-1 and RFP-SUMO-2 co-418	
expressing cells in response to H. pylori infection. RFP-vector (RFP) was used as a control for the 419	
RFP-fusion fragment without exogenous RFP-SUMO proteins. In contrast to the RFP/p38 co-420	
expressing control cells (Figure 7A, lane 4 and lane 7), in RFP-SUMO-1/p38 and RFP-SUMO-2/p38 421	
co-expressing cells, p-p38-WT (Figure 7A, lane 5 and lane 6) and p38-WT (Figure 7A, lane 5 and 422	
lane 6) as well as p38-DN (Figure 7A, lane 8 and lane 9) were all clearly observed in the N-fractions. 423	
These results are consistent with SUMO-mediated nuclear localization of p38 being independent of 424	
the p38 phosphorylation state. 425	
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Figure 7. SUMOs mediate the nuclear transport of p-p38, p38-WT and p38-DN. AGS cells co-427	
transfected with p38 proteins (wild type pCMV5-p38-WT and dominant negative pCMV5-p38-DN), 428	
and RFP-SUMOs were characterized for nuclear transfer of p38 and for SUMO-mediated p38 429	
apoptotic pathway during H. pylori infection. (A), p38-WT and p38-DN were blotted with anti-p-p38 430	
and anti p38 antibodies. Other antibodies used have been described in Figure 3. p38-DN was 431	
detected only using anti-p38 antibody, and not when anti-p-p38 antibody was used. p38 and p-p38 432	
proteins were clearly observed in the nuclear fraction only when co-transfected with RFP-SUMO-1  433	
and RFP-SUMO-2, and not distinctly when cotransfected with RFP alone, demonstrating that the 434	
nuclear localization is dependent on SUMOs. This effect was found to be independent of p38 435	
phosphorylation as the nuclear localization of the phosphorylation sites mutant p38-DN was also 436	
dependent on the presence of SUMOs. (B), p38 inhibitor (SB203580) was used in the MTT assay to 437	
show the effects of the increased levels of p38 and SUMOs in the p38 pathway. Compared with the 438	
basal state, p38-WT enhanced apoptosis (i.e., decreased cell survival), whereas p38-DN had no such 439	
function during H. pylori infection, highlighting the importance of p-p38, and consistent with p38-440	
DN being a non-activatable (non-phosphorylatable) p38. The Western blots (A) were repeated three 441	
times and representative images are shown. The MTT assays (B) were repeated four times and the 442	
results shown are the mean +/- standard deviation. Statistical analyses were performed using 443	
Student's T test. p<0.05 was considered significant; *= p<0.05; **= p<0.01; ***= p<0.001 444	
 445	
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A preliminary study on the apoptosis of AGS cells and GFP, wild type GFP-p38-WT and 446	
dominant negative GFP-p38-DN transfectants, incubated with or without H. pylori (300 MOI) for 12 447	
hours, stained with annexin-V were analyzed using flow cytometry as shown in Supplementary 448	
Figure 4. Results in Supplementary Figure 4B showed that up-regulation of apoptosis was observed 449	
upon overexpression of p38-WT (group 3 vs. group 2) and in response to Hp infection (black bar vs. 450	
white bar). No upregulation of apoptosis was seen upon overexpression of p38-DN (group 2 vs. 451	
group 4). 452	
 453	
Supplementary Figure 4. Up-regulation of apoptosis in response to Hp infection. AGS cells and GFP, 454	
wild type GFP-p38-WT and dominant negative GFP-p38-DN transfectants were incubated with or 455	
without H. pylori (300 MOI) 12 hours. A) The apoptotic cells stained with annexin-V were analyzed 456	
using flow cytometry in three separate experiments and representative traces from one such 457	
experiment are shown. B) The percentages of apoptosis increased in H. pylori infected cells (black 458	
bars) in comparison to the non-infected cells (white bars). Results shown are the mean +/- standard 459	
deviation for three experiments. The levels of apoptosis in the wild type GFP-p38-WT 460	
overexpression cells (group 3) were significantly increased in comparison to the dominant negative 461	
GFP-p38-DN overexpression cells (group 4) in both H. pylori infected and non-infected cells. There 462	
was no increase in apoptosis for GFP-p38-DN transfectants compared with the GFP control 463	
transfectants. 464	
The biological functions of phosphorylated p38-WT and non-phosphorylatable p38-DN were 465	
further analyzed using the MTT assay in p38/SUMO co-expressing cells during H. pylori infection 466	
(Figure 7B). In the absence of SB203580 p38 MAPK inhibitor (white bars), the results indicated that 467	
levels of cell survival in pCMV5-p38-DN transfectants (Figure 7B groups 7-9) were similar to that of 468	
pCMV5-vector transfectants (Figure 7B, groups 1-3), whereas the levels of cell survival were 469	
decreased in pCMV5-p38-WT transfectants (Figure 7B, groups 4-6) when compared with pCMV5-470	
vector control transfectants (Figure 7B, groups 1-3). Hence, the decrease in cell survival correlates 471	
with the presence of p-p38 in the nuclear fraction, particularly in the presence of SUMOs (groups 5 472	
and 6) where high levels of nuclear p-p38 give rise to the lowest cell survival. In the case of the non-473	
phosphorylatable p38 where there is no nuclear p-p38 (7A, N-fraction, Groups 7-9) the survival is 474	
not reduced (Figure 7B bars 7-9) and is very similar to that for the pCMV-vector only control 475	
(Figure 7B; bars 1-3). These results demonstrate that the non-functional non-phosphorylated p38 476	
(pCMV5-p38-DN), that cannot be phosphorylated in either the cytoplasm or in the nucleus, can be 477	
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transferred by SUMOs but has no effect on cell survival; whereas the functional wild type pCMV5-478	
p38-WT, that can be phosphorylated and can also be transferred by SUMOs is essential to exert an 479	
effect on viability. The results suggest that the nuclear transfer of p38 is SUMO-dependent, but 480	
independent of the phosphorylation state of p38, whereas p38-mediated apoptosis depends, as 481	
expected, upon nuclear p-p38. Cell survival was improved in all cases when cells were pretreated 482	
with SB203580 inhibitor (black bars) illustrating the importance of p38-mediated apoptosis. The 483	
decrease in cell-survival for the p38-WT cells was not completely reversed to the levels of the vector 484	
alone control, probably because of an incomplete block of the p38 pathway by the inhibitor. 485	
Similarly, the fact that the inhibitor exerts an effect on the cells lacking exogenous p-p38 (pCMV5 486	
and pCMV5-p38-DN) suggests it is acting on endogenous p38 in these cases. Taken together, these 487	
results show that the effects of SUMOs on cell survival measured by the MTT assay reflect 488	
modulation of p38-dependent apoptosis through modulation of nuclear p-p38 levels. 489	
Interestingly pull-down assays show that SUMO-2 binds better to p38 (phosphorylated or un-490	
phosphorylated) than SUMO-1 does (Figure 4B and Figure 6A), although p38 and p-p38 are not 491	
covalently modified by SUMOs (Figure 6B). However, the direct interaction between SUMOs and 492	
p38 and p-p38 supports the hypothesis that the cytoplasmic SUMOs serve as carrier proteins for the 493	
nuclear transfer of p38 and p-p38 through a non-covalent interaction. The p38 and p-p38 found in 494	
the N-fraction of the control RFP/p38-WT co-expressing cells was minimal as a result of small 495	
amounts of endogenous SUMOs, in contrast to the larger levels of p38 and p-p38 found in the N-496	
fraction of RFP-SUMOs/p38-WT co-expressing cells (Figure 7A). This highlights the importance of 497	
the expression levels of SUMOs for the nuclear relocation of p38 and p-p38 in response to H. pylori 498	
infection.The phosphorylation-dependent nuclear translocation of p38 has been suggested as a 499	
common phenomenon in response to various stresses. However, the results of our pull-down 500	
assays and nuclear fraction assays, suggest that the non-phosphorylatable p38-DN protein is 501	
associated with SUMOs and can be transferred to the nucleus by SUMOs (Figure 7). We now know 502	
that p38 and p-p38 are carried and transferred to the nucleus by SUMO-1 and SUMO-2 in the 503	
resting state (Figure 3). In contrast, in response to H. pylori infection it is the stress responsive 504	
SUMO-2 protein, with a stronger binding ability than SUMO-1 for p38 and p-p38, that serves as a 505	
major carrier to transfer p38 and p-p38 to the nucleus in response to H. pylori infection (Figure 3). 506	
This illustrates a new pathway for nuclear transfer of p38 through a non-covalent interaction with 507	
SUMOs that is independent of the p38 phosphorylation state. Moreover, in response to stress, not 508	
only p-p38 but also p38 are transferred to the nucleus by SUMOs, mostly by SUMO-2, in a SUMOs 509	
concentration-dependent manner. 510	
Our pull-down assays and cellular fraction assays for SUMOs/p38 SIM mutants (Figure 4) 511	
showed that SIM3 (amino acids 289LVLD292) is the most important site for binding to SUMOs. To 512	
conclude, this study demonstrates non-covalent interactions between p38 and SUMOs, independent 513	
of the phosphorylation state of p38. A mechanism for p38 and p-p38 nuclear translocation by 514	
SUMO carrier proteins in response to H. pylori infection is proposed. 515	
3. Discussion 516	
As a highly conserved subfamily of MAPKs, p38 proteins are important mediators of cellular 517	
responses to a wide variety of environmental stresses, including bacterial lipopolysaccharide (LPS)6, 518	
inflammation1, 2, ultraviolet radiation7, and oxidative stresses8. In resting cells, p38 is distributed 519	
both in the cytosol and the nucleus, and cytosolic p38 proteins translocate into the nucleus in 520	
response to various stimuli in order to access their nuclear substrates. Thus, the intracellular 521	
redistribution of p38 is an important mechanism by which p38 fulfils its cellular functions. 522	
Although there are theories suggested for nuclear translocation upon activation for all MAPK 523	
family members, the mechanism of p38 nuclear translocation is still not known5-9, 31-33. Since a typical 524	
NLS could not be identified in MAPKs, nor could direct interactions be detected between MAPKs 525	
and purified importins9, 31-33, it has been suggested that these proteins may undergo nuclear 526	
translocation either through interaction with other NLS-bearing proteins as carriers or, in the case 527	
of ERK, by a specific sequence that is designated as a nuclear translocation signal (NTS). However, 528	
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no such sequence has been identified in p38 as yet5 and the mechanisms of nuclear transport of p38 529	
and p-p38 remain unclear. Our study suggests that SUMOs are important mediators of p38 nuclear 530	
import. 531	
We found that H. pylori infection resulted in increased p38 activation and increased levels of 532	
SUMO-1 and SUMO-2 proteins, and that these increases were accompanied by p38-mediated 533	
cellular apoptosis. Manipulation of SUMO levels during H. pylori infection by either knockdown or 534	
overexpression, resulted in an increase or decrease in cell survival respectively. Hence we 535	
proceeded to investigate whether a direct interaction between p38 and SUMOs mediates this 536	
SUMO-dependent p38 effect on viability following H. pylori infection. 537	
Both the activation of p38 and nuclear localization of p38 and p-p38 were elevated significantly 538	
in RFP-SUMOs expressing cells, especially during H. pylori infection, further suggesting an 539	
association between SUMOs and p38. Furthermore, the results of the pull-down assays clearly 540	
demonstrated interactions between SUMOs and p38. In the absence of H. pylori infection both 541	
SUMO-1 and SUMO-2 contributed to the p38 nuclear localization, whereas in the presence of H. 542	
pylori only SUMO-2 was found to play this role. SUMOylation assays demonstrated that p38 is not 543	
covalently modifiable by SUMOs so we concluded that SUMOs mediate nuclear import by binding 544	
to p38/p-p38 through non-covalent interactions. The nature of this interaction was clarified by 545	
investigation of p38 SIM mutants, and results from pull-down and cellular fractionation assays 546	
showed that the SIM3 sequence (amino acids 289LVLD292) is the key mediator of the non-covalent 547	
interaction with SUMOs. Other studies have recently highlighted the biological importance of non-548	
covalent SUMO-SIM interactions34, 35e.g., a C-terminal SIM in the serine/threonine kinase HIPK2 is 549	
essential for its localization to nuclear speckles and its uptake in PML-NBs, while a SIM in the anti-550	
recombinogenic helicase Srs2 is essential for its interaction with SUMOylated PCNA (a DNA 551	
polymerase δ processivity factor essential for homologous recombination). 552	
The SUMO-mediated nuclear transport of p38 occurred equally well for wild type or for an 553	
inactive dominant negative form of p38 that could not be phosphorylated. We conclude that 554	
SUMO-2 is an important mediator of p38 nuclear transport in response to H.pylori infection via a 555	
non-covalent mechanism of binding that is independent of the p38 phosphorylation state, and that 556	
the SUMO-2-p38 interaction plays a key role in cell survival following H. pylori infection. It will be 557	
interesting to discover whether SUMO plays a similar role in the cellular response to other 558	
stressors. 559	
4. Materials and Methods  560	
4.1. Cell culture and H. pylori infection  561	
Gastric epithelial cell lines AGS (BCRC) were grown in RPMI-1640 purchased from Life 562	
Technologies Inc. The H. pylori strain ATCC 43504 (CagA+, VacA+) was maintained on CDC ANA 563	
blood agar (BD Biosciences) and resuspended in phosphate-buffered saline (PBS, Life 564	
Technologies)36. H. pylori were added to cells at a ratio of 300:1 bacteria to cells18.  565	
4.2. p38 SUMO-interacting motif (SIM) prediction and production of full length p38-SIM mutant 566	
constructs 567	
We divided p38α (MAPK14) into fragment-1 (1-110 amino acids), fragment-2 (111-180 amino 568	
acids) and fragment-3 (181-360 amino acids) (Figure 4). The pull-down assay showed that these 569	
fragments all interacted with SUMOs (results not shown). The highest probability putative SIMs 570	
predicted within these fragments by JASSA (http://www.jassa.fr/) and GPS-SBM 1.0 571	
(http://sbm.biocuckoo.org/) are 83VIGL86 (named p38-SIM1) in fragment-1, 164LKIL167 (p38-SIM2) in 572	
fragment-2 and 289LVLD292 (p38-SIM3) in fragment-3. Predicted SIMs from three SUMO-p38 573	
interacting fragments were individually mutated in the context of full-length p38 to give three full 574	
length p38-SIM mutants (p38-SIM1*, p38-SIM2* and p38-SIM3*) with two amino acid residues 575	
mutated in each. PCR fragments of p38-SIM1*, p38-SIM2* and p38-SIM3* coding sequences were 576	
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then created through overlap extension PCR, using pCMV5-p38-WT as a template, and cloned in 577	
pGEX-KG and pCMV5.	578	
4.3. Plasmids  579	
The p38α coding sequence was assembled by ligation of PCR fragments in the mammalian 580	
expression vector pCMV5 to make the wild type p38 construct (pCMV5-p38-WT). The dominant 581	
negative p38 construct (pCMV5-p38-DN) was created through site-direct mutagenesis using the 582	
QuikChange mutagenesis kit (Agilent) with pCMV5-p38-WT as a template. The PCR fragments of 583	
pCMV5-p38-WT and pCMV5-p38-DN coding sequences were ligated to the Escherichia coli (E. coli) 584	
expression vector pGEX-KG to create glutathione-S-transferase-tagged GST-p38-WT and GST-p38-585	
DN. The construction of pDsRed1-C1 (RFP, Clontech) fused plasmids for active SUMOs (RFP-586	
SUMO-1 and RFP-SUMO-2) and GST-Daxx4 (a GST fusion with the 607-740aa tail fragment of 587	
Daxx) was previously described18. All plasmid sequences were checked by sequencing analysis. 588	
4.4. Reverse-transcribed-PCR (RT-PCR) 589	
For cDNA synthesis 1µg of each RNA sample was reverse-transcribed. PCR products in 590	
agarose (Amresco) gels, visualized by ethidium bromide (EtBr, Sigma-Aldrich) staining were 591	
digitally photographed for intensity analysis. 592	
4.5. Transfections 593	
AGS cells were transfected using Lipofectamine 2000 (Life Technologies). Briefly, 4µl 594	
lipofectamine 2000 was mixed with 1.6µg of DNA in OPTI-MEM medium (Life Technologies) and 595	
added to approximately 1×106 cells. After 2hrs, the medium was removed and cells were cultured in 596	
fresh medium supplemented with 10% FBS. The transfectants were analyzed by Western blotting 597	
and MTT assay. 598	
4.6. Western blots 599	
AGS cell whole cell lysates were made as follows: AGS cells were harvested and resuspended 600	
in lysis buffer (1% Triton X-100 (Acros), 50mM Tris (pH7.9) (Merck Millipore), 5mM EDTA (Sigma-601	
Aldrich), 50mM NaF (Fluka), 0.1mM Na3VO4 (Sigma-Aldrich), 50mM N-ethylmaleimide (NEM, 602	
Sigma-Aldrich) and 1% protease inhibitor cocktail (Sigma-Aldrich)) on ice for 10 minutes. Western 603	
blotting was conducted as described previously18. 604	
4.7. Antibodies  605	
Antibodies used in this study included rabbit anti-phospho-p38 (Thr180/Thr182, #9211, Cell 606	
signaling), rabbit anti-p38 (#9212, Cell signaling), mouse anti-GAPDH (MAB374) (Merck Millipore), 607	
mouse anti-GMP1(SUMO-1) (18-2306, Life Technologies), rabbit anti-SUMO-2/3 (BML-PW9465, 608	
Enzo Life Sciences), rabbit anti-lamin A/C (#2032, Cell signaling), rabbit anti-RFP (632496, 609	
Clontech), rabbit anti-GST (71-7500, Life Technologies), rabbit anti-His (SC-803, Santa Cruz), 610	
horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (G21040, Life Technologies) and 611	
HRP-conjugated goat anti-rabbit IgG (G21234, Life Technologies). The rabbit anti-phospho-p38 and 612	
the rabbit anti-p38 used in this study can both react with the various isoforms of p38 (p38α, p38β, 613	
p38γ, and p38δ). However, the main isoform expressed in AGS cells is p38α, so this is referred to 614	
simply as p38 throughout the paper. 615	
4.8. MTT assay 616	
The colorimetric MTT assay was used to assess cell viability as follows. AGS cells (2×105 cells) 617	
were transfected with expression vectors for 24hrs, then treated with SB203580 MAPK inhibitor 618	
(10µM, Merck-Millipore) for 1h prior to H. pylori infection for 12hrs. 3-(4,5-Dimethylthiazol-2-yl)-619	
2,5-diphenyltetrazolium bromide (MTT) (12mM, Amresco) was added and incubated in the dark at 620	
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37oC for 4hrs. DMSO was added to dissolve the formazan crystals and read by spectrophotometer 621	
(BioTek). The results were calculated as percentages of the control (vehicle). 622	
4.9. In vitro p38 phosphorylation  623	
It is interesting to note that the ATP regeneration system in in vitro SUMOylation reactions 624	
could autophosphorylate GST-p38-WT (Figure 6B, group 1), as revealed by blotting with anti-p-p38 625	
antibodies; however, autophosphoryation did not occur at the dominant negative phosphorylation 626	
site mutant GST-p38-DN (Figure 6B, group 2). Therefore, this system was used to produce 627	
phosphorylated GST-p38-WT (GST-p-p38-WT) to enable us to examine the binding affinity between 628	
SUMOs and p-p38 in the pull-down assays. 629	
Reaction mixtures containing an ATP-regeneration system37 and GST-p38-WT proteins, were 630	
incubated for 3hrs at 37oC prior to in vitro pull-down assay. 631	
4.10. In vitro pull-down assay  632	
The in vitro pull-down assay was used to determine whether there was a physical interaction 633	
between 6-His tagged SUMOs and GST tagged p38 wild type or mutant proteins. It was performed 634	
by using 6×His-SUMOs (1-5µg) immobilized onto Ni-NTA Magnetic Agarose Beads (Qiagen) along 635	
with GST fusion proteins (1µg) in 500µl of binding buffer38 for 2hrs at room temperature. The beads 636	
were washed with wash buffer five times prior to elution of the bound proteins with SDS sample 637	
buffer and analysis by Western blotting. 638	
4.11. In vitro SUMOylation assay  639	
Recombinant GST and His fusion proteins were produced in E. coli strain BL21 and purified by 640	
standard methods. Each reaction sample contained an ATP-regeneration system37, GST-SAE1/2, 641	
GST-Ubc9, His-SUMO-1 or His-SUMO-2, and substrates of GST, GST-p38-WT, GST-p38-DN or 642	
GST-Daxx4. GST-Daxx was used as a positive control as it has previously been observed that GST-643	
Daxx was strongly modified by SUMO-1 and weakly modified by SUMO-2. The reactions were 644	
incubated at 37oC for 3hrs, then stopped by adding 1/5 vol. 6×SDS sample buffer, boiled and 645	
separated by SDS-PAGE. The SUMOylation products were analyzed by Western blotting. 646	
4.12. Nuclear and cytosolic isolation  647	
AGS cells were harvested and resuspended in cytosolic lysis buffer (0.1% NP40 (Amresco), 648	
10mM Tris (pH7.9), 10mM MgCl2 (Sigma-Aldrich), 15mM NaCl, 50mM NEM and 1% protease 649	
inhibitor cocktail) on ice for 10 minutes. After brief centrifugation, the supernatant was saved as the 650	
cytosolic fraction, and the nuclear pellet was lysed in SDS sample buffer. The cytosolic and nuclear 651	
fractions were analyzed by Western blotting. 652	
4.13. Statistical analyses  653	
Differences between groups were evaluated by an independent Student’s t-test using SPSS 654	
version 16.0 (SPSS Inc., USA). p<0.05 was considered significant 655	
 656	
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/link. 657	
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Abbreviations 676	
H. pylori       Helicobacter pylori 677	
MAPK       Mitogen-activated protein kinase 678	
MOI         Multiplicity of infection 679	
SIM         SUMO interacting motif 680	
SUMO-1     Small ubiquitin-like modifier-1 681	
SUMOs      Small ubiquitin-like modifier-1 or 2 682	
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